12
Views
15
CrossRef citations to date
0
Altmetric
Original Papers

Autocrine Motility Factor Receptor Expression Implies an Unfavourable Prognosis in Resected Stage I Pulmonary Adenocarcinomas

, , , , &
Pages 378-382 | Published online: 11 Mar 2016

References

  • Mountain C. F. Revisions in the international system for staging lung cancer. Chest, 1997, 111: 1710–7.
  • Nesbitt J. C., Putnam J. B., Walsh G. L., Roth J. A., Mountain C. F. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg, 1995, 60: 466–72.
  • Choi Y. S., Shim Y. M., Kim S. H. et al. Prognostic significance of E-cadherin and ß-catenin in resected stage I non-small cell lung cancer. Eur J Cardiothorac Surg, 2003, 24: 441–9.
  • Sakao Y., Tomimitsu S., Takeda Y., Natsuaki M., Itoh T. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. Eur J Cardiothorac Surg, 2004, 25: 520–2.
  • D’amico T. A., Massey M., Herndon J. E., Moore M. B., Harpole D. H. A biological risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with ten molecular markers. J Thorac Cardiovasc Surg, 1999, 117: 736–43.
  • Volk T., Geiger B., Raz A. Motility and adhesive properties of high-and low-metastatic murine neoplastic cells. Cancer Res, 1984, 44: 811–24.
  • Evans C. P., Walsh D. S., Kohn E. C. An autocrine motility factor secretes by the Dunning R-3327 rat prostatic adenocarcinoma cell sub-type AT2.1 Int J Cancer, 1991, 49: 109–13.
  • Rozen E. M., Goldberg I. D. Protein factors which regulate cell motility. In Vitro CellDevBiol, 1989, 25: 1079–87.
  • Watanabe H., Carmi P., Hogan v. et al. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem, 1991, 266: 13442–8.
  • Watanabe H., Shinozaki T., Raz A., Chigira M. Expression of autocrine motility factor receptor in serum-and protein-independent fibrosarcoma cells: implications for autonomy in tumor-cell motility and metastasis. Int J Cancer, 1993, 53: 689–95.
  • Maruyama K., Watanabe H., Shiozaki H. et al. Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma. Int J Cancer, 1995, 64: 316–21.
  • Hirono Y., Fushida A., Yonemura Y., Yamamoto H., Watanabe H., Raz A. Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer. Br J Cancer, 1996, 74 :, 2003–7.
  • Kara M., Ohta A., Tanaka Y., Oda M., Watanabe Y. Autocrine motility factor receptor expression in patients with stage i non-small cell lung cancer. Ann Thorac Surg, 2001, 71: 944–8.
  • Otto T., Birchmeier W., Schmidt U. et al. Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res, 1994, 54: 3120–3.
  • Nakamori S., Watanabe H., Kameyama M. et al. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. Cancer, 1994, 74: 1855–62.
  • Travis W. D., Colby T. v., Corrin B., Shimosato Y., Brambilla E. Histological Typing of Pleural Tumours. 3rd ed. Berlin: SpringerVerlag, 1999.
  • Nabi I. R., Watanabe H., Raz A. Identification of B16-F1 melanoma autocrine motility-like factor receptor. Cancer Res, 1990, 50: 409–14.
  • Siletti S., Watanabe H., Hogan v., Nabi I. R., Raz A. Purification of B16-F1 melanoma autocrine motility-like factor and its receptor. Cancer Res, 1991, 51: 3507–11.
  • Takanami I., Takeuchi K, Watanabe H., Yanagawa H., Takagishi K., Raz A. Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer. Int J Cancer, 2001, 20: 384–7.
  • Sayar A., Turna A., Solak O., Kilicgun A., Urer N., Gurses A. Nonanatomic prognostic factors in resected non-small cell lung carcinoma: the importance of perineural invasion as a new prognostic marker. Ann Thorac Surg, 2004, 77: 421–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.